Skip to main content
Premium Trial:

Request an Annual Quote

Carl Feldbaum

Trovagene has appointed Carl Feldbaum to its board. He will chair the company's corporate governance and nominating committee. From 1993 to 2005, Feldbaum was president of the Biotechnology Industry Organization, and he currently is on the boards of Actelion Pharmaceuticals and Exelixis. He also serves as director of BIO Ventures for Global Health, and The Life Sciences Foundation. He previously served as chief of staff to Sen. Arlen Specter of Pennsylvania. 

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.